Howe Jolanda 的 Form 4 申報
Mirum Pharmaceuticals, Inc.（MIRM），2025/3/18 申報
- 申報編號
- 0001415889-25-008558
- 申報時間
- 2025/3/18
- 交易日
- 2025/3/15-3/17
- 申報延遲
- 3 天
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $255.5 萬。交易後 3 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Howe JolandaCIK 0001974200 | 高階主管（SVP, GLOBAL CONTROLLER） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/3/15 | Common Stock | M行使選擇權取得 | +5,315 | –F1 | – | 9,547 | 直接 | |
| 2025/3/17 | Common Stock | S賣出處分 | −2,900 | $44.21 | −$128,209 | 6,647 | 直接 | |
| 2025/3/17 | Common Stock | M行使選擇權取得 | +52,900 | $2.94 | +$155,526 | 59,547 | 直接 | |
| 2025/3/17 | Common Stock | S賣出處分 | −50,111 | $44.33F4 | −$2,221,420.63 | 9,436 | 直接 | |
| 2025/3/17 | Common Stock | S賣出處分 | −2,789 | $44.75F5 | −$124,807.75 | 6,647 | 直接 | |
| 2025/3/17 | Common Stock | S賣出處分 | −1,806 | $44.36F6 | −$80,114.16 | 4,841 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/3/15 | Common Stock | M行使選擇權處分 | −5,315 | $0.00 | $0 | 2,658 | 直接 | |
| 2025/3/17 | Common Stock | M行使選擇權處分 | −52,900 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The weighted average sale price for the transaction reported was $44.33410, and the range of prices were between $43.695 and $44.695. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The weighted average sale price for the transaction reported was $44.74811, and the range of prices were between $44.70 and $44.84. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The weighted average sale price for the transaction reported was $44.35923, and the range of prices were between $43.81 and $44.71. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。